Factors to Consider When Choosing Between Tesamorelin and Ipamorelin 1
(FDA Label) (2024) Tesamorelin: Uses, Dosage, Side Effects, Warnings Drugs.com (AHFS Monograph & Patient Info) (2025) Tesamorelin LiverTox (Safety Profile) NIH NIDDK LiverTox Database (2018) Administration of Parenteral Medications Nursing Skills (Open RN Textbook) Open RN, Chippewa Valley Technical College (2023) Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
Lab test interactions: Note that sermorelin can cause transient changes in certain lab values
Accredited labs can detect its metabolites
The animals display a 50 % reduction in intrauterine growth, impaired glucose tolerance, and a decrease in glucose uptake stimulated by insulin or IGF-1 in vivo and in vitro
[ 4 , 5 , 6 ] In November 2010, the FDA approved Tesamorelin under the brand name Egrifta after Phase III clinical trials demonstrated that Tesamorelin significantly reduced visceral adipose tissue without affecting subcutaneous adipose tissue to a clinically significant extent
